Drug Retail(IN00277.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Drug Retail
IN00277.US
News
View More

Pre-market hot trades in US stocks: Concorde up 12.22% in pre-market; 111 Inc. up 8.20% in pre-market

Concorde pre-market up 12.22%; 111 Inc. pre-market up 8.20%; Gelteq pre-market up 56.04%; XCF Global pre-market up 46.61%; China Su Xuan Tang Pharmaceutical pre-market up 32.30%

Tracking Unusual Activity·
US
CIGL
+0.56%
US
YI
+15.20%
Tracking Unusual Activity·
US
CIGL
+0.56%
US
YI
+15.20%

U.S. stock market midday update: 111 Inc. rises 49.3% in 5 days, with active capital flow, sector trends attract volatility attention

111 Inc. rose 16.99%; SRX Health Solutions fell 4.90%, with a transaction volume of $1.71 million; Mangoceuticals fell 3.03%, with a transaction volume of $132,300; Ridgetech rose 1.51%, with a transaction volume of $8,179

Tracking Unusual Activity·
US
YI
+15.20%
Tracking Unusual Activity·
US
YI
+15.20%

Ridgetech Inc On December 29, 2025 Co Entered Into Sales Agreement With Ac Sunshine Securities -SEC Filing

Dec 30 (Reuters) - Ridgetech Inc:* RIDGETECH INC: ON DECEMBER 29, 2025 CO ENTERED INTO SALES AGREEMENT WITH AC SUNSHINE SECURITIES -SEC FILING* RIDGETECH : MAY OFFER AND SELL ORDINARY SHARES OF CO HAVING OFFERING PRICE OF UP TO $200 MILLION-SEC FILING Source text: Further company coverage:

Reuters·
US
RDGT
+2.37%
Reuters·
US
RDGT
+2.37%

Solana Price Approaches $130: What’s Behind The Recent Surge?

Solana's price surged 6% to near $126, driven by the Solana Foundation's quantum-resistant testnet and Mangoceuticals' $100 million investment in SOL. Despite this, technical analysis indicates a downtrend with significant resistance at $133-$138 and $144-$147. Immediate support is at $125, with potential dips to $100 or lower if liquidations increase. Analysts caution that sustained recovery requires closing above the low-$130s with higher trading volume.

NewsBTC·
US
HSDT
+1.16%
US
MGRX
-2.99%
NewsBTC·
US
HSDT
+1.16%
US
MGRX
-2.99%

Mangoceuticals, Inc. closes $2.5M offering and private placements with investors for health and wellness products.

On Dec. 19, 2025, Mangoceuticals, Inc. (NASDAQ: MGRX) revealed the completion of its registered direct offering and private placement with institutional investors. The Company distributed Common Stock, pre-funded warrants, and investor warrants in the offerings, generating about $2.5 million in total gross proceeds. The transactions took place under Nasdaq rules and concluded on the same day. Mangoceuticals specializes in health and wellness products sold through the MangoRx and PeachesRx brands on a secure telemedicine platform.

Unusual Whales·
US
MGRX
-2.99%
Unusual Whales·
US
MGRX
-2.99%
© 2026 Longbridge｜Disclaimer